We also performed multivariable analysis, but only borderline significant values were observed for the on-TKI duration and presence of mutations at diagnosis (Supplemental Table 3 ).
← all excerpts
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation.
1
—
—